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urpose: Hypodontia is the congenital absence of one or more (up to six) permanent and/or deciduous teeth, being one of
the most common alterations of the human dentition. Genetic polymorphisms are variations of DNA sequences occurring in a
population. This study investigated whether G-915C single nucleotide polymorphism (SNPs) in the PAX9 gene promoter is
associated with hypodontia in humans. Material and Methods: The polymorphism in region G/C-915 of PAX9 gene (NCBI ref
SNP ID:  rs 2073247) of 240 patients was analyzed, being 110 controls and 130 individuals with third molar agenesis. After DNA
extraction, the region of interest was amplified by PCR technique using two different primers. The significance of the differences
in observed frequencies of polymorphisms in both groups was assessed by odds-ratio and chi-squared test with 95% confidence
interval. Results: Genotype CC was more frequent in patients with agenesis (11.5%) compared to the control (1.8%), while GG
was more prevalent in the control group (39.1%) compared to the individuals with agenesis (26.2%). Conclusion: These data
showed that the allele C could be associated with the third molar agenesis.
Uniterms: Hypodontia; PAX9 transcription factor; Tooth abnormalities; Genetic polymorphism.
INTRODUCTION
Hypodontia, the congenital absence of one or a few teeth,
is one of the most common developmental alterations of
human dentition. Hypodontia is not a serious public health
problem, but it may cause masticatory (temporomandibular
joint disorders) and speech dysfunctions and create esthetic
problems with orthodontic and prosthetic impairments29. In
the past few years, several growth and transcription factors
have been shown to be expressed in developing teeth26.
The direct participation of several genes in tooth
development was demonstrated by the lack of teeth in
mutant knockout mice models7. Autosomal dominant forms
of hypodontia have been shown to be caused by mutations
in the MSX1 and PAX9 genes in human families25. However,
the origin of the isolated sporadic agenesis, the most
common form of hypodontia in humans, is still unknown.
To date only a limited number of mutations of MSX1 and
PAX9 have been proven to be associated with severe
hypodontia (oligodontia) in humans11.
PAX9 is a transcription factor that is expressed in dental
mesenchyme at initiation, bud, cap and bell stages of
odontogenesis15. Protein products of this gene serve as
transcription factors that are responsible for the crosstalk
between epithelial and mesenchymal tissues and are
essential for the establishment of the odontogenic potential
of the mesenchyme23,27. It has been found that PAX9-deficient
mice lack teeth and pharyngeal pouches derivates and have
severe craniofacial anomalies16. The expression of PAX9 in
the mesenchyme appears to be a marker for the sites of
tooth formation as it occurs before any morphological
manifestation of this process12. Mutations in this gene have
been shown to be associated with autosomal dominant forms
of oligodontia (agenesis of more than 6 teeth, MIM 604625)
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in humans10,25. In most families, mutations occur in exon 2
affecting the function of PAX9 paired domain that is
responsible for the binding of this protein to DNA target
sequences. Affected individuals have severe tooth agenesis
with absence of most molars, second premolars and some
incisors. PAX9 is critical for the regulation of BMP4
expression through its paired domain rather than Msx113.
Polymorphisms are a mechanism by which individuals
may exhibit variations within the range of what is considered
biologically normal. Gene polymorphisms have also been
associated with susceptibility to diseases. Most
polymorphisms are single nucleotide exchanges that occur
at a high frequency in the human genome and may affect
the function of genes. Although it has been demonstrated
that mutations in the coding sequences of PAX9 are a
causative factor in familiar forms of severe tooth agenesis,
polymorphisms in this gene have not been associated with
sporadic tooth agenesis.
Previous studies have shown that two polymorphisms
in the PAX9 promoter region seem to be associated to the
dental agenesis in human beings (G-1031A, T-912C T-160C).
The purpose of the present study was to investigate whether
the G-915C single nucleotide polymorphism (SNPs) in the
PAX9 gene promoter is associated with hypodontia in
humans15,22.
MATERIAL AND METHODS
Subject Selection and Sampling
One hundred and thirty unrelated Caucasian individuals
with hypodontia, without signs of other disorders and 110
healthy control individuals (without hypodontia) were
interviewed and documented. Congenital absence of teeth
was confirmed by X-ray examination. No other dental
anomalies were observed in the subjects. The sampling of
epithelial buccal cells was performed as previously
described15. Briefly, individuals undertook a mouthwash of
5 mL 3% glucose. Following mouthwash, a sterile wooden
spatula was used to scrape oral mucosa. The tip of the
spatula was then shacked into the retained mouthwash
solution. Buccal epithelial cells were pelleted by
centrifugation at 2000 rpm for 10 min. The supernatant was
discarded and the cell pellet resuspended in 500 µL extraction
buffer [10 mM Tris-HCl (pH 7.8), 5 mM EDTA, 0.5% SDS].
The samples were then frozen at -20oC until used for DNA
extraction. After defrosted, samples were incubated
overnight with 100 ng/mL proteinase K (Sigma Chemical
Co., St. Louis, MO, USA) at 37°C with agitation. DNA was
then purified by sequential phenol/chloroform extraction
and salt/ethanol precipitation. DNA was dissolved in 70 µL
TE buffer [10 mM Tris (pH 7.8), 1 mM EDTA]. The
concentration was estimated by measurements of OD 26015.
Polymerase Chain Reaction (PCR)
Amplification of the PAX9 gene fragment was performed
with the oligonucleotides 5’AGC CTG AAT CCT GTG TGC
AC-3´ (forward) and two reverses to amplify the region with
alleles G or C. To amplify the alelles G the oligonucleotide
5’GAA ATA TTT TCG TGA ATT TGG GAG’-3´ was used
and the C allele was amplified with the oligonucleotide
5’ATT TTC GTG AAT TTG GGAC’-3´ (NCBI ref SNP ID: rs
2073245). Reactions were conducted in a total volume of 50
ìL, containing: 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1 mM
of each primer, 200 mM each dATP, dCTP, dGTP and dTTP,
25 mM MgCl2 and 2.5 units Taq DNA polymerase
(Amersham Pharmacia Biotech, Uppsala, Sweden). The
thermal cycling conditions consisted of an initial
denaturation at 95°C for 5 min followed by 35 cycles of 95°C
for 60 sec, annealing at 56°C for 70 sec, and a final extension
at 72°C for 70 sec. Reactions were performed on a GeneAmp®
PCR System 2400 thermocycler (Perkin Elmer).
PCR products of PAX9 were submitted to 10%
polyacrylamide gel electrophoresis and the DNA bands were
labeled by silver staining15.
Statistical Analysis
The significance of the differences in observed
frequencies of polymorphisms in both groups was assessed
by odds-ratio and chi-squared test with 95% confidence
interval. All statistical analysis was conducted using
BioEstat program version 2.0. Differences were considered
significant at p<0.0515.
RESULTS
The statistical analysis showed significant differences
in the alleles and genotypes frequencies in the promoter
polymorphisms of PAX9 gene (G-915C). The C allele was
found in 31.4% of the control group and in 42.5% of the test
group (individuals with hypodontia) (p=0.0014). The G/G
and C/C genotypes frequencies were 39.1% and 1.8% in the
control group and 26% and 11.4% in the test group
respectively (p=0.0045). The frequencies of different alleles
and genotypes of the PAX9 gene are shown in Table 1. The
association was confirmed when the CC genotype is
confronted with CG/GG. Individuals with CC genotype
seemed to be seven times more susceptible to develop
hypodontia (OR= 7.04; 95% CI= 1.1-15.2; p= 0.0034).
DISCUSSION
The G-915C polymorphism in the 5’ flanking region of
PAX9 gene could be associated with hypodontia in humans.
CC genotype was found at a significant higher frequency in
individuals with hypodontia. Analysis of human families
shows a strong effect of PAX9 mutations on third molar
agenesis, whereas mutations in this gene have a weaker but
fairly evident effect on the development of incisors and
premolars.4-6,18-20,24,28. Three other polymorphic alleles (T-
160C, G–1031A and T–912C) located close to the
polymorphic region evaluated here were also associated
with hypodontia in humans22.
Families bearing PAX9 mutation had tooth agenesis as
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the only clinical sign. The relative lack of pleiotropy of
mutations in PAX9 and on other genes affecting the dental
field would account for the common variation in the form
and number of teeth observed in humans and other
mammals2. This would allow genetic changes to affect the
earlier phases of tooth development, without interfering
significantly with the development of other organs16.
Experimental and theoretical approaches have stressed
the importance of cis-regulatory DNA sequences that
control the transcription of genes as the basic modular unit
that determine the positional information in developing
structures3. The cis-regulatory sequences of many genes
are organized into independent modules that regulate the
transcription of specific tissues at specific times during
development7. The regulatory modules are usually
constituted of multiple binding sites for transcription factors
that can be located near the transcription start site, or
thousand of base pairs away1. Mutations within individual
modules can enhance or repress gene transcription in a
tissue specific manner, allowing a mutation to exert its effect
on a few or even a single morphogenetic field7. A relevant
fact is the relative lack of pleiotropic effects of PAX9 gene
mutations in humans. Families bearing PAX9 mutation had
tooth agenesis as the only clinical sign. The relative lack of
pleiotropy of mutations in PAX9 gene and on other genes
affecting the dental area would account for the common
variation in the form and number of teeth observed in
humans and other mammals2. This would allow genetic
changes to affect the earlier phases of tooth development,
without interfering significantly with the development of
other organs.
For example, the down-regulation of Msx1 expression in
PAX9-deficient mice and decreased levels of Bmp4
expression in PAX9 and Msx1 homozygous null mice indicate
that the three genes act within the same signaling pathway.
Although recent studies of human PAX9 mutations have
enabled structure-function correlations, the precise
molecular mechanisms that contribute to tooth agenesis are
poorly understood. The functional studies of a previously
described mutation (L21P) in the amino-terminal
subdomain of the PAX9 paired domain demonstrate
impaired transcriptional activation of the Msx1 and Bmp4
promoters. It is likely that the proline cyclic side chain blocks
the main chain nitrogen atom and chemically prevents it
from forming a hydrogen bond13.
In humans, the changes in the number of teeth tend to
occur in the reverse of the sequence that teeth are formed
during development, which also characterizes the general
pattern of tooth loss observed during the evolution of
placental mammals17. Variations in tooth number may have
represented an important factor in the diversification of
mammalian species. Like hypodontia, most evolutionary
changes in tooth number resulted from the loss of one or
two elements, in most cases the last member of a tooth
family. In this regard, the study of genetic polymorphisms
in tooth agenesis is a specially suited model to understand
the association of gene polymorphisms and changes in
morphology. Teeth are serially homologous structures and
the effects of gene variations on the development of these
structures can be easily quantified8. Individuals with distinct
polymorphic alleles may exhibit subtle and specific
phenotypic variations in dental patterning. In this sense,
association studies between gene polymorphisms and
hypodontia as well as other mild malformations that reflect
qualitative defects of embryogenesis14, may help
understanding the molecular mechanisms responsible for
the phenotypic variations that may occur in distinct human
populations and ethnic groups.
The first mutation described in human PAX9 gene was
an insertion of an additional G within the paired box
sequence at nucleotide 219 (219InsG) of exon 2 in a family
with oligodontia. Since then eight additional mutations in
the coding region of PAX9 gene were reported being
associated with oligodontia in humans8. Seven out of the
G-915C Control Third molar agenesis
Genotype n % n %
GG 43 39.1 34 26.2
GC 65 59.1 81 62.4
CC 2 1.8 15 11.5
p 0.0045
CC 2 1.8 15 11.5
GG/GC 108 98.2 115 88.5
p* 0.0034
OR (95%Cl) 7.04(1.1-15.2)
Allele n % n %
G 151 68.6 150 57.5
C 112 31.4 110 42.5
p 0.0014
TABLE 1- Genotype and allele distribution of the G-915C polymorphism of PAX9 gene in the  control and hypodontia (third
molar) groups
 p*: chi-squared test.
384
BIANCHI F J, OLIVEIRA T F de, SAITO C B P, PERES R C R, LINE S R P
nine reported mutations were located in the paired domain
at exon 2. Recently, it has been shown that the 219InsG
frameshift mutation dramatically reduces DNA binding of
the PAX9 paired domain and supports the hypothesis that
loss of DNA binding is the pathogenic mechanism by which
the mutation causes oligodontia9. Although mutations in
the coding sequences of PAX9 and MSX1 genes are a
causative factor in familiar forms of oligodontia6, the genetic
origin of the isolated sporadic agenesis, the most common
form of hypodontia in humans, is still unknown. We report
here that three other polymorphisms (T-160C, G-1031A and
T-912C) in the 5’ flanking region of PAX9 gene are associated
with hypodontia in humans. Other alleles, such as C (-160),
A (-1031) and C (-912) were found at a significant higher
frequency in individuals with hypodontia. A comparative
analysis of mouse, rat and human PAX9 5’ flanking
sequences shows that the T-160C is located in a poorly
conserved region when human and rodent (mice and rat)
sequences are compared. Although the present study
showed a positive association on genotype and odds ratio,
the results must be confirmed by studies with other
populations and functional experiments, such as
homologous recombination in mice, gel shift analysis and
reporter gene systems.
CONCLUSION
The findings of this study showed that the allele C could
be associated with third molar agenesis.
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